CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
Unlearn.AI
start up
United States
- San Francisco, California
- 19/04/2022
- Series B
- $50,000,000
Accelerating clinical trials with AI.
- Industry Biotechnology
- Website https://www.unlearn.ai/
- LinkedIn https://www.linkedin.com/company/unlearn-ai/
Related People
Charles FisherFounder
United States -
San Francisco Bay Area
Solving the most challenging problems in biology and healthcare using statistical physics and machine learning.
Contacting me:
I am not open to full-time employment opportunities and will not respond to related messages.
LinkedIn
https://www.linkedin.com/in/drckf/
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)